NZ293994A - Immortalized endothelial brain cell lines and their use in therapy - Google Patents

Immortalized endothelial brain cell lines and their use in therapy

Info

Publication number
NZ293994A
NZ293994A NZ293994A NZ29399495A NZ293994A NZ 293994 A NZ293994 A NZ 293994A NZ 293994 A NZ293994 A NZ 293994A NZ 29399495 A NZ29399495 A NZ 29399495A NZ 293994 A NZ293994 A NZ 293994A
Authority
NZ
New Zealand
Prior art keywords
therapy
cell lines
brain cell
immortalized endothelial
endothelial brain
Prior art date
Application number
NZ293994A
Other languages
English (en)
Inventor
Nathalie Chaverot
Pierre-Olivier Couraud
John Laterra
Jerome Quinonero
Francoise Roux
Arthur Donny Strosberg
Jean-Leon Tchelingerian
Lionel Vignais
Original Assignee
Neurotech Sa Substituted Under
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotech Sa Substituted Under filed Critical Neurotech Sa Substituted Under
Publication of NZ293994A publication Critical patent/NZ293994A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ293994A 1994-10-10 1995-10-09 Immortalized endothelial brain cell lines and their use in therapy NZ293994A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9412078A FR2726005B1 (fr) 1994-10-10 1994-10-10 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
PCT/FR1995/001313 WO1996011278A1 (fr) 1994-10-10 1995-10-09 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
NZ293994A true NZ293994A (en) 1999-02-25

Family

ID=9467723

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ293994A NZ293994A (en) 1994-10-10 1995-10-09 Immortalized endothelial brain cell lines and their use in therapy

Country Status (7)

Country Link
EP (1) EP0787197A1 (xx)
JP (1) JPH10507074A (xx)
AU (1) AU715289B2 (xx)
CA (1) CA2202066A1 (xx)
FR (1) FR2726005B1 (xx)
NZ (1) NZ293994A (xx)
WO (1) WO1996011278A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047938A2 (en) * 1998-01-12 2000-11-02 Betagene, Inc. Identification of substances that modify cellular secretory function
US6093553A (en) * 1998-11-25 2000-07-25 Boehringer Ingelheim Pharmaceuticals, Inc. Immortalized brain endothelial cells
AU1404400A (en) * 1998-11-30 2000-06-19 Neurotech Sa Mammalian non-neuronal cells that are modified to store and release a neurotransmitter
FR2787464B1 (fr) * 1998-12-21 2003-01-10 Neurotech Compositions pharmaceutiques comprenant des cellules endotheliales immortalisees pour la detection et/ou le traitement des sources angiogeniques et tout particulierement des cancers
FR2787463B1 (fr) * 1998-12-21 2001-03-30 Neurotech Preparation de cellules de mammifere eventuellement transfectees avec un gene codant pour une substance active et les compositions les contenant
KR100674140B1 (ko) * 1999-03-23 2007-01-26 다카라 바이오 가부시키가이샤 유전자 치료제
AU2001259422A1 (en) * 2000-05-03 2001-11-12 Neurotech Sa Immortalized lines of endothelial brain cells and therapeutic application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3851153T2 (de) * 1987-12-11 1995-01-05 Whitehead Biomedical Inst Genetische modifizierung von endothelialen zellen.
WO1992007943A1 (en) * 1990-10-31 1992-05-14 Somatix Therapy Corporation Retroviral vectors useful for gene therapy
JPH06509467A (ja) * 1991-04-04 1994-10-27 アメリカ合衆国 内皮細胞の不死化
FR2681609B1 (fr) * 1991-09-24 1994-12-30 Centre Nat Rech Scient Lignees de cellules endotheliales cerebrales immortalisees, leur procede de preparation et leurs applications en tant que modele d'etude de la physiopathologie cerebrale.
US5336615A (en) * 1992-01-06 1994-08-09 Yale University Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity
AU3429993A (en) * 1992-01-10 1993-08-03 Georgetown University A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy
GB9222931D0 (en) * 1992-11-02 1992-12-16 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
JPH10507074A (ja) 1998-07-14
EP0787197A1 (fr) 1997-08-06
AU3657595A (en) 1996-05-02
FR2726005A1 (fr) 1996-04-26
AU715289B2 (en) 2000-01-20
CA2202066A1 (fr) 1996-04-18
FR2726005B1 (fr) 1997-01-03
WO1996011278A1 (fr) 1996-04-18

Similar Documents

Publication Publication Date Title
EP0463474A3 (en) Cationic microgels and their use in electrodeposition
PL327610A1 (en) Quinoline and quinozoline compounds useful in therapy
GB9311276D0 (en) Well inserts for use in tissue culture
GB2303321B (en) Improvements in and relating to grinding
IL118119A0 (en) Azacycloalkane derivatives their preparation and their application in therapy
GB2301161B (en) Improvements in and relating to fixing
GB2275029B (en) Improvements in and relating to wheelchairs
GB9419678D0 (en) Improvements in and relating to headphones
AP9500727A0 (en) 13-substituted milbemy in derivatives their preparation and use
NZ293994A (en) Immortalized endothelial brain cell lines and their use in therapy
GB9502584D0 (en) Improvements in and relating to wwarf removal
ZA983740B (en) Novel amidine derivatives and their use in therapy
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
GB9501706D0 (en) Improvements in and relating to supports
GB2292690B (en) Improvements in and relating to training aids
IL113347A (en) Brain endothelial cell protein and methods for its use
GB2314250B (en) Improvements in and relating to sheep handling
GB9625041D0 (en) Improvements in and relating surfaces
GB2290232B (en) Body and back support
GB2311218B (en) Improvements in and relating to baths
GB9508450D0 (en) Improvements in and relating to lifting apparatus
AU5764399A (en) Antigen-presenting cells and their use in therapy
GB9405372D0 (en) Improvements in and relating to crushing apparatus
GB9317248D0 (en) Improvements in and relating to training aids
GB2286006B (en) Improvements in and relating to partition apparatus

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)